FGAs are more persistent than and at least as potent as other nerve agents. FGAs may require more aggressive supportive care, greater amounts of medication, and a longer duration of treatment.
Along with supportive care and patient decontamination, the mainstays of managing nerve agent toxicity, including FGA toxicity, are anticholinergics (e.g., atropine), oxime AChE reactivators (e.g., pralidoxime chloride, or 2-PAM), and anticonvulsants (e.g., the benzodiazepines - diazepam, midazolam, and lorazepam).
